"Esophageal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ESOPHAGUS.
| Descriptor ID |
D004938
|
| MeSH Number(s) |
C04.588.274.476.205 C04.588.443.353 C06.301.371.205 C06.405.117.430 C06.405.249.205
|
| Concept/Terms |
Esophageal Neoplasms- Esophageal Neoplasms
- Esophageal Neoplasm
- Neoplasm, Esophageal
- Esophagus Neoplasm
- Esophagus Neoplasms
- Neoplasm, Esophagus
- Neoplasms, Esophagus
- Neoplasms, Esophageal
Cancer of Esophagus- Cancer of Esophagus
- Cancer of the Esophagus
- Esophagus Cancer
- Cancer, Esophagus
- Cancers, Esophagus
- Esophagus Cancers
- Esophageal Cancer
- Cancer, Esophageal
- Cancers, Esophageal
- Esophageal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Esophageal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Esophageal Neoplasms".
This graph shows the total number of publications written about "Esophageal Neoplasms" by people in this website by year, and whether "Esophageal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 2 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 5 | 0 | 5 |
| 2007 | 4 | 1 | 5 |
| 2008 | 3 | 1 | 4 |
| 2009 | 10 | 1 | 11 |
| 2010 | 7 | 1 | 8 |
| 2011 | 8 | 0 | 8 |
| 2012 | 15 | 0 | 15 |
| 2013 | 13 | 6 | 19 |
| 2014 | 13 | 0 | 13 |
| 2015 | 19 | 2 | 21 |
| 2016 | 14 | 2 | 16 |
| 2017 | 10 | 2 | 12 |
| 2018 | 19 | 0 | 19 |
| 2019 | 15 | 0 | 15 |
| 2020 | 11 | 0 | 11 |
| 2021 | 12 | 1 | 13 |
| 2022 | 16 | 1 | 17 |
| 2023 | 8 | 1 | 9 |
| 2024 | 8 | 2 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Esophageal Neoplasms" by people in Profiles.
-
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study. ESMO Open. 2025 Feb; 10(2):104107.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. ESMO Open. 2024 Nov; 9(11):103934.
-
A High-Resolution Microendoscope Improves Esophageal Cancer Screening and Surveillance: Implications for Underserved Global Settings Based on an International Randomized Controlled Trial. Gastroenterology. 2025 Mar; 168(3):496-507.e3.
-
Comparative Outcomes and Toxicity in Patients With Esophageal Cancer After Trimodality Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy: The MD Anderson Experience. Clin Oncol (R Coll Radiol). 2025 Feb; 38:103668.
-
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish. J Clin Oncol. 2025 Jan 20; 43(3):339-349.
-
Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes. Blood Adv. 2024 10 08; 8(19):5215-5224.
-
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma. N Engl J Med. 2024 Sep 26; 391(12):1159-1162.
-
Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials. ESMO Open. 2024 Aug; 9(8):103663.
-
Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma. J Surg Oncol. 2024 Sep; 130(3):428-434.